<p>Enovix（纳斯达克代码：ENVX - 获取免费报告）于周四公布了季度财报。该公司报告每股收益（EPS）为（$0.13），超出市场共识预期的（$0.15）$0.02，Briefing.com 报道。Enovix 的净利润率为 -481.35%，股本回报率为 -72.83%。该公司在本季度的收入为 750 万美元，而分析师的预期为 548 万美元。在去年同期，该公司的每股收益为（$0.14）。公司的收入同比增长了 98.2%。Enovix 更新了其 2025 年第三季度的指引，预计每股收益为 -0.180 到 -0.140。</p>
<h2>Enovix 股票表现</h2>
<ul>
<li>5 只夏季回购的热门股票，你可以获利</li>
</ul>
<p>在周五的午盘交易中，纳斯达克：ENVX 下跌了 $2.70，报 $10.70。该公司的股票交易量为 24,263,913 股，而其平均交易量为 10,370,709 股。该公司的市值为 20.5 亿美元，市盈率为 -12.74，贝塔值为 2.11。Enovix 的 52 周低点为 $5.27，52 周高点为 $16.49。该公司的 50 日移动平均线为 $10.99，200 日移动平均线为 $9.38。公司的债务与股本比率为 0.71，流动比率为 4.68，速动比率为 4.49。</p>
<h2>分析师设定新目标价</h2>
<p>ENVX 一直是几份研究分析报告的主题。Craig Hallum 在 7 月 8 日的研究报告中重申了 “买入” 评级，并将 Enovix 的目标价从 $12.00 上调至 $15.00。TD Cowen 在 7 月 7 日的研究报告中将 Enovix 的评级上调至 “持有”，并将其目标价从 $7.00 上调至 $15.00。B. Riley 在 7 月 10 日的研究报告中重申了 “买入” 评级，并将 Enovix 的目标价从 $12.00 上调至 $17.00。Benchmark 在 7 月 25 日的研究报告中将 Enovix 的目标价从 $15.00 上调至 $25.00，并给予该公司 “买入” 评级。最后，摩根大通在 7 月 24 日的研究报告中重申了 “中性” 评级，并将 Enovix 的目标价从 $9.00 上调至 $12.00。一位股票研究分析师对该股票给予了卖出评级，五位给予了持有评级，六位给予了买入评级。根据 MarketBeat 的数据，Enovix 目前的共识评级为 “持有”，共识目标价为 $18.60。</p>
<ul>
<li>Enovix 股价创六个月新高；长期高点将随之而来</li>
</ul>
<p><strong>阅读我们最新的 ENVX 股票分析</strong></p>
<h2>Enovix 的机构交易</h2>
<p>几家机构投资者和对冲基金最近买卖了 ENVX 的股票。高盛集团在第一季度将其在 Enovix 的持股比例提高了 65.4%。高盛集团目前拥有 1,137,777 股该公司的股票，价值 $8,351,000，此前在上个季度购买了额外的 449,934 股。瑞银资产管理公司（UBS AM）在第一季度将其在 Enovix 的持股比例提高了 18.4%。瑞银资产管理公司目前拥有 358,023 股该公司的股票，价值 $2,628,000，此前在上个季度购买了额外的 55,676 股。未来资产全球 ETF 持有有限公司在第一季度将其在 Enovix 的持股比例提高了 5.1%。未来资产全球 ETF 持有有限公司目前拥有 98,318 股该公司的股票，价值 $722,000，此前在上个季度购买了额外的 4,780 股。NewEdge Advisors LLC 在第一季度将其在 Enovix 的持股比例提高了 10.4%。NewEdge Advisors LLC 目前拥有 26,257 股该公司的股票，价值 $193,000，此前在上个季度购买了额外的 2,481 股。最后，Caxton Associates LLP 在第一季度购买了 Enovix 的新股份，价值约 $190,000。目前 50.92% 的股票由对冲基金和其他机构投资者持有。</p>
<ul>
<li>3 只有望翻倍的股票——现在仍有时间购买</li>
</ul>
<p>Enovix 宣布其董事会已于 7 月 2 日授权了一项股票回购计划，允许公司回购价值 $6000 万的流通股。该回购授权允许公司通过公开市场购买最多 3.1% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>关于 Enovix</h2>
<p>（获取免费报告）</p>
<p>Enovix 公司设计、开发和制造硅负极锂离子电池。它服务于可穿戴设备和物联网、智能手机、笔记本电脑和平板电脑、工业和医疗以及电动车行业。该公司成立于 2007 年，总部位于加利福尼亚州弗里蒙特。</p>
<h2>阅读更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Enovix</li>
<li>2 只有望在 2025 年大幅上涨的 CRM 平台股票</li>
<li>比特币和股息：这 3 只 ETF 的赢家组合</li>
<li>电动车股票及其获利方式</li>
<li>PG&amp;E 是 AI 的投资机会吗？为什么期权交易者在大举押注</li>
<li>什么样的股票是好的股息股票？</li>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Enovix 吗？</h2>
<p>在你考虑 Enovix 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而 Enovix 并不在名单上。</p>
<p>虽然 Enovix 目前在分析师中被评为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ENVX

<p>Enovix（纳斯达克代码：ENVX）报告的季度每股收益为（$0.13），超出预期的（$0.15）$0.02。收入达到 750 万美元，超过预期的 548 万美元，同比增长 98.2%。该公司的净利润率为-481.35%，股本回报率为-72.83%。Enovix 更新了其 2025 年第三季度的指引，预计每股收益在-0.180 到-0.140 之间。分析师设定的共识目标价为$18.60，评级包括买入、持有和卖出。该公司还授权了一项 6000 万美元的股票回购计划</p>

<p>Enovix (NASDAQ:ENVX - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02, Briefing.com reports. Enovix had a negative net margin of 481.35% and a negative return on equity of 72.83%. The firm had revenue of $7.50 million during the quarter, compared to analysts' expectations of $5.48 million. During the same period in the prior year, the company posted ($0.14) EPS. The company's revenue was up 98.2% on a year-over-year basis. Enovix updated its Q3 2025 guidance to -0.180--0.140 EPS.</p>
<div class="lb-trans"><p>Enovix（纳斯达克代码：ENVX - 获取免费报告）于周四公布了季度财报。该公司报告每股收益（EPS）为（$0.13），超出市场共识预期的（$0.15）$0.02，Briefing.com 报道。Enovix 的净利润率为 -481.35%，股本回报率为 -72.83%。该公司在本季度的收入为 750 万美元，而分析师的预期为 548 万美元。在去年同期，该公司的每股收益为（$0.14）。公司的收入同比增长了 98.2%。Enovix 更新了其 2025 年第三季度的指引，预计每股收益为 -0.180 到 -0.140。</p>
</div><h2>Enovix Stock Performance</h2>
<div class="lb-trans"><h2>Enovix 股票表现</h2>
</div><ul>
<li>5 Hot Stocks With Summer Buybacks You Can Cash In On</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只夏季回购的热门股票，你可以获利</li>
</ul>
</div><p>NASDAQ:ENVX traded down $2.70 during midday trading on Friday, hitting $10.70. The company's stock had a trading volume of 24,263,913 shares, compared to its average volume of 10,370,709. The firm has a market cap of $2.05 billion, a P/E ratio of -12.74 and a beta of 2.11. Enovix has a fifty-two week low of $5.27 and a fifty-two week high of $16.49. The firm's 50 day moving average is $10.99 and its 200-day moving average is $9.38. The company has a debt-to-equity ratio of 0.71, a current ratio of 4.68 and a quick ratio of 4.49.</p>
<div class="lb-trans"><p>在周五的午盘交易中，纳斯达克：ENVX 下跌了 $2.70，报 $10.70。该公司的股票交易量为 24,263,913 股，而其平均交易量为 10,370,709 股。该公司的市值为 20.5 亿美元，市盈率为 -12.74，贝塔值为 2.11。Enovix 的 52 周低点为 $5.27，52 周高点为 $16.49。该公司的 50 日移动平均线为 $10.99，200 日移动平均线为 $9.38。公司的债务与股本比率为 0.71，流动比率为 4.68，速动比率为 4.49。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>ENVX has been the topic of several research analyst reports. Craig Hallum reissued a &#34;buy&#34; rating and set a $15.00 target price (up from $12.00) on shares of Enovix in a research note on Tuesday, July 8th. TD Cowen raised shares of Enovix to a &#34;hold&#34; rating and raised their price objective for the company from $7.00 to $15.00 in a research note on Monday, July 7th. B. Riley reaffirmed a &#34;buy&#34; rating and issued a $17.00 price objective (up from $12.00) on shares of Enovix in a research note on Thursday, July 10th. Benchmark raised their price objective on shares of Enovix from $15.00 to $25.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, July 25th. Finally, JPMorgan Chase &amp; Co. reaffirmed a &#34;neutral&#34; rating and issued a $12.00 price objective (up from $9.00) on shares of Enovix in a research note on Thursday, July 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, Enovix currently has a consensus rating of &#34;Hold&#34; and a consensus target price of $18.60.</p>
<div class="lb-trans"><p>ENVX 一直是几份研究分析报告的主题。Craig Hallum 在 7 月 8 日的研究报告中重申了 “买入” 评级，并将 Enovix 的目标价从 $12.00 上调至 $15.00。TD Cowen 在 7 月 7 日的研究报告中将 Enovix 的评级上调至 “持有”，并将其目标价从 $7.00 上调至 $15.00。B. Riley 在 7 月 10 日的研究报告中重申了 “买入” 评级，并将 Enovix 的目标价从 $12.00 上调至 $17.00。Benchmark 在 7 月 25 日的研究报告中将 Enovix 的目标价从 $15.00 上调至 $25.00，并给予该公司 “买入” 评级。最后，摩根大通在 7 月 24 日的研究报告中重申了 “中性” 评级，并将 Enovix 的目标价从 $9.00 上调至 $12.00。一位股票研究分析师对该股票给予了卖出评级，五位给予了持有评级，六位给予了买入评级。根据 MarketBeat 的数据，Enovix 目前的共识评级为 “持有”，共识目标价为 $18.60。</p>
</div><ul>
<li>Enovix Shares Hit 6-Month High; Long-Term Highs to Follow</li>
</ul>
<div class="lb-trans"><ul>
<li>Enovix 股价创六个月新高；长期高点将随之而来</li>
</ul>
</div><p><strong>Read Our Latest Stock Analysis on ENVX</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 ENVX 股票分析</strong></p>
</div><h2>Institutional Trading of Enovix</h2>
<div class="lb-trans"><h2>Enovix 的机构交易</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of ENVX. Goldman Sachs Group Inc. lifted its stake in Enovix by 65.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company's stock worth $8,351,000 after purchasing an additional 449,934 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Enovix by 18.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company's stock valued at $2,628,000 after buying an additional 55,676 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Enovix by 5.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company's stock valued at $722,000 after buying an additional 4,780 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Enovix by 10.4% in the first quarter. NewEdge Advisors LLC now owns 26,257 shares of the company's stock valued at $193,000 after buying an additional 2,481 shares during the last quarter. Finally, Caxton Associates LLP purchased a new stake in Enovix in the first quarter valued at approximately $190,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近买卖了 ENVX 的股票。高盛集团在第一季度将其在 Enovix 的持股比例提高了 65.4%。高盛集团目前拥有 1,137,777 股该公司的股票，价值 $8,351,000，此前在上个季度购买了额外的 449,934 股。瑞银资产管理公司（UBS AM）在第一季度将其在 Enovix 的持股比例提高了 18.4%。瑞银资产管理公司目前拥有 358,023 股该公司的股票，价值 $2,628,000，此前在上个季度购买了额外的 55,676 股。未来资产全球 ETF 持有有限公司在第一季度将其在 Enovix 的持股比例提高了 5.1%。未来资产全球 ETF 持有有限公司目前拥有 98,318 股该公司的股票，价值 $722,000，此前在上个季度购买了额外的 4,780 股。NewEdge Advisors LLC 在第一季度将其在 Enovix 的持股比例提高了 10.4%。NewEdge Advisors LLC 目前拥有 26,257 股该公司的股票，价值 $193,000，此前在上个季度购买了额外的 2,481 股。最后，Caxton Associates LLP 在第一季度购买了 Enovix 的新股份，价值约 $190,000。目前 50.92% 的股票由对冲基金和其他机构投资者持有。</p>
</div><ul>
<li>3 Stocks Set to Double—And There's Still Time to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只有望翻倍的股票——现在仍有时间购买</li>
</ul>
</div><p>Enovix declared that its Board of Directors has authorized a stock buyback program on Wednesday, July 2nd that allows the company to repurchase $60.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Enovix 宣布其董事会已于 7 月 2 日授权了一项股票回购计划，允许公司回购价值 $6000 万的流通股。该回购授权允许公司通过公开市场购买最多 3.1% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>About Enovix</h2>
<div class="lb-trans"><h2>关于 Enovix</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.</p>
<div class="lb-trans"><p>Enovix 公司设计、开发和制造硅负极锂离子电池。它服务于可穿戴设备和物联网、智能手机、笔记本电脑和平板电脑、工业和医疗以及电动车行业。该公司成立于 2007 年，总部位于加利福尼亚州弗里蒙特。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Enovix</li>
<li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025</li>
<li>Bitcoin and Dividends: A Winning Combo in These 3 ETFs</li>
<li>EV Stocks and How to Profit from Them</li>
<li>Is PG&amp;E an AI Power Play? Why Options Traders Are Betting Big</li>
<li>What Makes a Stock a Good Dividend Stock?</li>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Enovix</li>
<li>2 只有望在 2025 年大幅上涨的 CRM 平台股票</li>
<li>比特币和股息：这 3 只 ETF 的赢家组合</li>
<li>电动车股票及其获利方式</li>
<li>PG&amp;E 是 AI 的投资机会吗？为什么期权交易者在大举押注</li>
<li>什么样的股票是好的股息股票？</li>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=ENVX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Enovix Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Enovix 吗？</h2>
</div><p>Before you consider Enovix, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Enovix 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而 Enovix 并不在名单上。</p>
</div><p>While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Enovix 目前在分析师中被评为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Enovix（NASDAQ:ENVX）公布季度财报结果